🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Jessica Armand

Jessica Armand

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer”.

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

eLife(2025)10.7554/elife.104545

N/A

0.275DataRank · unranked

4 citations

Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin Kalinsky +2 more

Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer

Cell Reports(2023)10.1016/j.celrep.2023.113198

N/A

0DataRank · unranked

57 citations

Jessica Armand, Anton Safonov, Mimi Zhang, Rajesh K. Soni, Gary K. Schwartz +7 more

Targeting CDK4/6 in breast cancer

Experimental & Molecular Medicine(2025)10.1038/s12276-025-01395-3

N/A

0DataRank · unranked

45 citations

Jessica Armand, Eugene Son, Hee Won Yang, Anusha Shanabag

E2F activity determines mitosis versus whole-genome duplication in G2-arrested cells

Nature Communications(2025)10.1038/s41467-025-62061-w

N/A

0DataRank · unranked

7 citations

Jessica Armand, Sungsoo Kim, Hee Won Yang, Kibum Kim

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

eLife(2025)10.7554/elife.104545.1

N/A

0DataRank · unranked

0 citations

Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Hee Won Yang +1 more

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

eLife(2025)10.7554/elife.104545.2

N/A

0DataRank · unranked

0 citations

Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin Kalinsky +2 more